Glen D. Stettin

Glen D. Stettin

Director/Board Member at MEDAVAIL HOLDINGS, INC.

Net worth: - $ as of 28/02/2024

60 year
Consumer Services
Retail Trade
Commercial Services

Profile

Glen D.
Stettin
is an Independent Director at MedAvail Holdings, Inc., and a Senior VP at Express Scripts, Inc. He is also the Chief Innovation Officer & Senior VP-Research at Express.
Scripts Holding Co. Stettin has previously served as an Independent Director at PRA Health Sciences, Inc., a Director at MedAvail, Inc., and as the Chief Medical Officer & Senior Vice President at Medco Health Solutions, Inc. Stettin holds an undergraduate degree from Lehigh University and a doctorate from Drexel University College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/06/2023 0 ( -.--% ) - $ 28/02/2024

Glen D. Stettin active positions

CompaniesPositionStart
EXPRESS SCRIPTS HOLDING CO Corporate Officer/Principal 31/03/2012
MEDAVAIL HOLDINGS, INC. Director/Board Member 17/11/2020
Chief Tech/Sci/R&D Officer 04/07/2012
All active positions of Glen D. Stettin

Former positions of Glen D. Stettin

CompaniesPositionEnd
Director/Board Member 31/01/2022
PRA HEALTH SCIENCES, INC. Director/Board Member 30/06/2021
Chief Tech/Sci/R&D Officer 31/03/2012
See the detail of Glen D. Stettin's experience

Training of Glen D. Stettin

Lehigh University Undergraduate Degree
Drexel University College of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Glen D. Stettin's experience

Connections

100 +

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MEDAVAIL HOLDINGS, INC.

Health Technology

Private companies5

Retail Trade

Commercial Services

Health Services

Finance

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Glen D. Stettin